ALGERT GLOBAL LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 141 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALGERT GLOBAL LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$338
+20.3%
86,813
+5.0%
0.02%0.0%
Q4 2022$281
-99.9%
82,668
-13.8%
0.02%
-50.0%
Q3 2022$524,000
-18.0%
95,958
-32.2%
0.03%
-33.3%
Q2 2022$639,000
+27.0%
141,590
+81.0%
0.05%
-23.8%
Q4 2021$503,000
-1.2%
78,239
-10.6%
0.06%
-7.4%
Q3 2021$509,000
+35.7%
87,539
+141.0%
0.07%
-46.0%
Q2 2021$375,00036,3200.13%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 5,158,884$30,128,0001.90%
Palo Alto Investors LP 5,262,263$30,732,0001.28%
Private Capital Advisors, Inc. 444,900$2,598,0000.79%
Capital Impact Advisors, LLC 153,449$1,401,0000.62%
FIRST MIDWEST BANK TRUST DIVISION 610,850$3,567,0000.48%
EMERALD ADVISERS, LLC 1,508,094$8,807,0000.36%
Virtus ETF Advisers LLC 27,391$160,0000.34%
EMERALD MUTUAL FUND ADVISERS TRUST 1,376,475$8,039,0000.32%
Birchview Capital, LP 70,000$409,0000.26%
Telemetry Investments, L.L.C. 50,000$292,0000.15%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders